CXCL1 and neoplasm: Specifically, recovery of both IL-6 (tumor treatment effect: F2,34 = 11.8, p < 0.0001; Fig. 5B) and CXCL1 (tumor treatment effect: F2,34 = 17.1, p < 0.0001; Fig. 5D) was attenuated for tumor-bearing mice relative to both tumor-free and -resected mice.